Ask AI
ProCE Banner Activity

Improving Equity in HCV Care Through Universal Screening and Treatment Simplification: Updates From EASL 2025

Clinical Thought

In this commentary I highlight how studies presented at the EASL 2025 demonstrate innovative strategies for HCV testing, treatment monitoring, and approaches to care.

Released: June 12, 2025

Expiration: December 11, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Disclosure

Primary Author

Stefan Zeuzem, MD: consultant/advisor/speaker: AbbVie, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Ipsen, Madrigal, Merck Sharp & Dohme, Novo Nordisk.